Milyon USD cinsinden finanslar. Mali yıl Şubat - Ocak'tır.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Hasılat
14
13
12
11
9
9
Hasılat Artışı (YoY)
8%
8%
9%
22%
0%
13%
Satınalma Maliyeti
5
5
4
4
3
3
Brüt Kâr
8
8
7
6
5
5
Satış, Genel ve İdari
8
8
7
6
6
5
Araştırma ve Geliştirme
0
0
0
0
0
0
İşletme Giderleri
8
8
8
7
6
5
Diğer Finansman Gelirleri (Giderleri)
0
0
0
2
0
3
Kâr Öncesi Gelir
0
0
0
0
0
2
Kira Vergisi Gideri
--
--
--
--
--
--
Net Kâr
0
0
0
0
0
2
Net Income Growth
Kâr Artışı
--
--
--
--
-100%
-300%
Dolaşım Daki Hisse Senetleri (Dilüte Edilmiş)
528.08
522.28
517.77
510.79
477.72
431.21
Hisse Değişimi (Yıllık Üst Üste)
1%
1%
1%
7%
11%
3%
EPS (Diluted)
0
0
0
0
0
0.01
EPS Artışı
-43%
-100%
--
--
-100%
--
Öz sermaye akışı
0
0
0
-1
0
1
Hisse Başı Öz Kaynak Akışı
--
--
--
--
--
--
Brüt Karşılık
57.14%
61.53%
58.33%
54.54%
55.55%
55.55%
Faaliyet Kâr Marjı
0%
0%
0%
-9.09%
0%
0%
Kâr Marjı
0%
0%
0%
0%
0%
22.22%
Özsermaye Karlılık Oranı
0%
0%
0%
-9.09%
0%
11.11%
EBITDA
0
0
0
-1
0
0
EBITDA Marjinali
0%
0%
0%
-9.09%
0%
0%
D&A EBITDA için
0
0
0
0
0
0
Faaliyet Kârı
0
0
0
-1
0
0
Faaliyet Kâr Marjı
0%
0%
0%
-9.09%
0%
0%
Verilen Vergi Oranı
--
--
--
--
--
--
Önemli İstatistikler
Önceki Kapanış
$0.0956
Açılış fiyatı
$0.0911
Günün Aralığı
$0.0675 - $0.0953
52 haftalık aralık
$0.0345 - $0.11
İşlem hacmi
33.7K
Ort.Hacim
91.2K
EPS (TTM)
-0.00
Dividend yield
--
Piyasa Değeri
$35.6M
INIS nedir?
International Isotopes, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. The company is headquartered in Idaho Falls, Idaho and currently employs 41 full-time employees. The firm's segments include Theranostics Products, Cobalt Products, Nuclear Medicine Standards, Medical Device Products and Fluorine Products. Theranostics Products segment includes production and distribution of its generic sodium iodide I-131 drug product for the treatment of hyperthyroidism and carcinoma of the thyroid. Cobalt Products segment includes the production of bulk cobalt (cobalt-60), fabrication of cobalt capsules for radiation therapy and various industrial applications. Nuclear Medicine Standards segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET) imaging. Fluorine Products segment is involved in the production of small-scale qualification samples of high-purity fluoride gas for various industrial applications. The company is working to launch the RadVent brand of medical devices.